Aim: To determine the effect of safranal on diabetic retinopathy and its possible mechanisms.
Methods: We used human retinal microvascular endothelial cells (HRMECs) to test the influence of safranal . High glucose damage was established and an safranal was tested at various concentrations for its potential to reduce cell viability using the MTT assay.
Aim: To determine the effects of safranal on choroidal neovascularization (CNV) and oxidative stress damage of human choroidal microvascular endothelial cells (HCVECs) and its possible mechanisms.
Methods: Forty-five rats were used as a laser-induced CNV model for testing the efficacy and safety of safranal (0.5 mg/kg·d, intraperitoneally) on CNV.